Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of dermatological science (Amsterdam)

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jdermsci.2016.03.003PMID 27211019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biology and principles of scar management and burn reconstruction.

  2014cited by this paper
• Effect of Human Wharton's Jelly Mesenchymal Stem Cell Paracrine Signaling on Keloid Fibroblasts

  2014cited by this paper
• Management of Fibrosis: The Mesenchymal Stromal Cells Breakthrough

  2014cited by this paper
• Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective

  2014cited by this paper
• New insights on keloids, hypertrophic scars, and striae.

  2014cited by this paper
• Treg‐enriched CD4+ T cells attenuate collagen synthesis in keloid fibroblasts

  2014cited by this paper
• Human Wharton’s jelly mesenchymal stem cells promote skin wound healing through paracrine signaling

  2014cited by this paper
• Application of stems cells in wound healing—An update

  2014cited by this paper
• Human Keloid Cell Characterization and Inhibition of Growth with Human Wharton's Jelly Stem Cell Extracts

  2014cited by this paper
• Site-Specific Keloid Fibroblasts Alter the Behaviour of Normal Skin and Normal Scar Fibroblasts through Paracrine Signalling

  2013cited by this paper
• An Experimental Novel Study: Angelica sinensis Prevents Epidural Fibrosis in Laminectomy Rats via Downregulation of Hydroxyproline, IL-6, and TGF-β1

  2013cited by this paper
• Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.

  2013cited by this paper
• Mesenchymal stem cell therapy in skin: why and what for?

  2013cited by this paper
• Concise Review: Clinical Translation of Wound Healing Therapies Based on Mesenchymal Stem Cells

  2012cited by this paper
• Site‐specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates

  2012cited by this paper
• Wound Repair and Regeneration

  2012cited by this paper
• Mesenchymal stem cell therapy for attenuation of scar formation during wound healing

  2012cited by this paper
• Cutaneous wound healing: recruiting developmental pathways for regeneration

  2012influential reference
• Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

  2012cited by this paper
• PAI‐1 in tissue fibrosis

  2012cited by this paper
• Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues

  2012cited by this paper
• Small Leucine-Rich Proteoglycans

  2011cited by this paper
• Adenovirus-Mediated Human Interleukin 24 (MDA-7/IL-24) Selectively Suppresses Proliferation and Induces Apoptosis in Keloid Fibroblasts

  2011cited by this paper
• Small leucine‐rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar

  2011cited by this paper
• The evidence for the role of transforming growth factor‐beta in the formation of abnormal scarring

  2011cited by this paper
• Adipose-Derived Stem Cells for Wound Healing Applications

  2011cited by this paper
• Anti‐fibrotic effect of chorionic plate‐derived mesenchymal stem cells isolated from human placenta in a rat model of CCl4‐injured liver: Potential application to the treatment of hepatic diseases

  2010cited by this paper
• CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model.

  2010cited by this paper
• Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair.

  2010cited by this paper
• CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model.

  2010cited by this paper
• Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis.

  2010cited by this paper
• Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial

  2009cited by this paper
• Adenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblasts.

  2008cited by this paper
• Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.

  2007cited by this paper
• Transforming growth factor-beta and fibrosis.

  2007cited by this paper
• Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries.

  2004cited by this paper
• Wound repair and regeneration

  1994cited by this paper
• Transforming Growth Factor β in Tissue Fibrosis

  1994cited by this paper
• Transforming growth factor beta in tissue fibrosis.

  1994cited by this paper

• Mesenchymal Stem Cells-Derived Exosomes: Next-Generation Nanomedicines Toward Scarless Wound Healing.

  2026cites this paper
• Assessing the Protective Role of Wharton's Jelly-Derived Mesenchymal Stem Cell Secretomes in Inducing Apoptosis in SKBR3 Breast Carcinoma Cells

  2025cites this paper
• Single-cell–guided repositioning of Sorafenib enables nano-immunotherapy for scarless burn healing

  2025cites this paper
• Efficient protocol for isolating human fibroblast from primary skin cell cultures: application to keloid, hypertrophic scar, and normal skin biopsies

  2024cites this paper
• Future Directions About Keloid Scars Based on Pathogenesis and Therapies

  2024cites this paper
• Emerging technologies in regenerative medicine: The future of wound care and therapy

  2024cites this paper
• ADSCC‐CM‐Induced Keratin Hydrogel‐Based Bioactive Microneedle Patch Containing Triamcinolone Acetonide for the Treatment of Pathological Scar

  2024cites this paper
• The impact of subdermal adipose derived stem cell injections and early excision on systemic oxidative stress and wound healing in rats with severe scald burns.

  2024cites this paper
• Enhancing neurite growth and neural functions on polymeric nerve conduit with BMSC-derived ECM coating

  2024cites this paper
• Development and optimization of the Glabridin-loaded dissolving microneedle for enhanced treatment of keloid

  2024cites this paper
• Stem cell-based therapy for fibrotic diseases: mechanisms and pathways

  2024cites this paper
• Pharmacotherapy for Keloids and Hypertrophic Scars

  2024cites this paper
• Human dental pulp stem cells for burn wound healing: Potential therapeutic applications.

  2024cites this paper
• Revealing the Therapeutic Potential of Stem Cells in Burn Healing: A Deeper Understanding of the Therapeutic Mechanisms of Epidermal Stem Cells and Mesenchymal Stem Cells

  2024cites this paper
• Inhibition of Small Extracellular Vesicles by GW4869 Does not Disrupt the Paracrine Regulation of Adipose-Derived Mesenchymal Stem Cells Over Keloid Fibroblasts

  2024cites this paper
• Secretome Analysis of Human Nasal Fibroblast Identifies Proteins That Promote Wound Healing.

  2023cites this paper
• Effects of Stem Cell Therapy on Keloid Treatment: A Literature Review

  2023influential citation
• Dendrobium officinale Kinura et Migo glycoprotein promotes skin wound healing by regulating extracellular matrix secretion and fibroblast proliferation on the proliferation phase

  2023cites this paper
• Therapeutic role of exosomes and conditioned medium in keloid and hypertrophic scar and possible mechanisms

  2023cites this paper
• Treatment with Exosomes Derived from Mesenchymal Stem Cells: A New Window of Healing Science in Regenerative Medicine.

  2023cites this paper
• Anti-Fibrotic Effects of RF Electric Currents

  2023cites this paper
• An updated review of the immunological mechanisms of keloid scars

  2023cites this paper
• The Effect of Stromal Vascular Fraction on Scar Formation of Transverse Rectus Abdominis Muscle Flap Donor Sites: A Pilot Study

  2022cites this paper
• Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial.

  2022cites this paper
• [Research advances on the characteristics of fibroblast in keloid].

  2022cites this paper
• Downregulation of PLK4 expression induces apoptosis and G0/G1‐phase cell cycle arrest in keloid fibroblasts

  2022cites this paper
• The Effect of Stromal Vascular Fraction on Scar Formation of Transverse Rectus Abdominis Muscle Flap Donor Sites: A Pilot Study

  2022cites this paper
• Mesenchymal Stem/Stromal Cells and Fibroblasts: Their Roles in Tissue Injury and Regeneration, and Age-Related Degeneration

  2021cites this paper
• Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring

  2021cites this paper
• An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases

  2021cites this paper
• Chitosan-Based Functional Materials for Skin Wound Repair: Mechanisms and Applications

  2021cites this paper
• Emerging and Novel Therapies for Keloids

  2021cites this paper
• Therapeutic Strategies by Regulating Interleukin Family to Suppress Inflammation in Hypertrophic Scar and Keloid

  2021cites this paper
• Evaluation of the Effects of Human Dental Pulp Stem Cells on the Biological Phenotype of Hypertrophic Keloid Fibroblasts

  2021cites this paper
• Update on management of keloid and hypertrophic scars: A systemic review

  2021cites this paper
• Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment.

  2021cites this paper
• Stem Cell Therapy for Burns: Story so Far

  2021cites this paper
• Advances in Skin Wound and Scar Repair by Polymer Scaffolds

  2021cites this paper
• Identification and functional analysis of a three-miRNA ceRNA network in hypertrophic scars

  2021cites this paper
• Stem Cell Therapy for Burns: Story so Far

  2021cites this paper
• Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia

  2020cites this paper
• Improving Chronic Diabetic Wound Healing through an Injectable and Self-Healing Hydrogel with Platelet-Rich Plasma Release.

  2020cites this paper
• Adipose stem cell secretion combined with biomaterials facilitates large-area wound healing.

  2020cites this paper
• MicroRNA124 and microRNA21-5p regulate migration, proliferation and differentiation of rat bone marrow mesenchymal stem cells

  2020cites this paper
• Combination of mesenchymal stem cell-conditioned medium and botulinum toxin type A for treating human hypertrophic scars.

  2020cites this paper
• Evaluation of epithelial progenitor cells and growth factors in a preclinical model of wound healing induced by mesenchymal stromal cells

  2020cites this paper
• Efficacy and safety of umbilical cord mesenchymal stem cells in treatment of cesarean section skin scars: a randomized clinical trial

  2020cites this paper
• Healing of deep dermal burns by allogeneic mesenchymal stromal cell transplantation

  2020cites this paper
• Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars

  2020cites this paper
• The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models

  2020influential citation
• Progress of Mesenchymal Stem Cell-Derived Exosomes in Tissue Repair.

  2020cites this paper
• Extracellular Vesicles Derived From Human Adipose-Derived Stem Cell Prevent the Formation of Hypertrophic Scar in a Rabbit Model

  2020cites this paper
• Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring

  2020cites this paper
• Inhibition of growth of Asian keloid cells with human umbilical cord Wharton’s jelly stem cell-conditioned medium

  2020cites this paper
• Human Atrial Fibroblast Adaptation to Heterogeneities in Substrate Stiffness

  2020cites this paper
• Running title : MicroRNA 124 and microRNA 21-5 p regulate MSCs behaviors

  2020influential citation
• Multi‐dimensional models for functional testing of keloid scars: In silico, in vitro, organoid, organotypic, ex vivo organ culture, and in vivo models

  2019cites this paper
• A thermosensitive RGD-modified hydroxybutyl chitosan hydrogel as a 3D scaffold for BMSCs culture on keloid treatment.

  2019cites this paper
• Keloids – an extensive review in the light of recent literature

  2019cites this paper
• Biological approaches for hypertrophic scars

  2019cites this paper
• In Vitro and Ex Vivo Models for Functional Testing of Therapeutic Anti-scarring Drug Targets in Keloids

  2019influential citation
• Scarring and Scar Management

  2019cites this paper
• Platelet-Rich Plasma and Bone Marrow-Derived Mesenchymal Stromal Cells Prevent TGF-β1-Induced Myofibroblast Generation but Are Not Synergistic when Combined: Morphological in vitro Analysis

  2019cites this paper
• Chemokine Pathway Can Be the Potential Therapeutic Target for Hypertrophic Scar

  2019cites this paper
• Apigenin inhibits growth and migration of fibroblasts by suppressing FAK signaling

  2019cites this paper
• In vivo migration of Fe3O4@polydopamine nanoparticle-labeled mesenchymal stem cells to burn injury sites and their therapeutic effects in a rat model.

  2019cites this paper
• The role and mechanism of transforming growth factor beta 3 in human myocardial infarction‐induced myocardial fibrosis

  2019cites this paper
• miR-188-5p regulates proliferation and invasion via PI3K/Akt/MMP-2/9 signaling in keloids

  2019cites this paper
• Advancements in Regenerative Strategies Through the Continuum of Burn Care

  2018cites this paper
• Granulation tissue-derived mesenchymal stromal cells: a potential application for burn wound healing in pediatric patients

  2018cites this paper
• Stem Cell Therapy for Tendon Regeneration: Current Status and Future Directions.

  2018cites this paper
• IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways

  2018cites this paper
• Conditioned Medium Obtained from Amnion-Derived Mesenchymal Stem Cell Culture Prevents Activation of Keloid Fibroblasts

  2018cites this paper
• Efficiency of Adipose-Derived versus Bone Marrow-Derived Stem Cells in Modulation of Histopathological Changes and CD31 Immunoexpression during Wound Healing in Rats

  2018cites this paper
• Destructive and Reparative Processes in Rat's Skin After Burn in Presence of Stem and Progenitor Cell Bioregulators

  2018cites this paper
• Knockdown of elF3a inhibits TGF‑β1‑induced extracellular matrix protein expression in keloid fibroblasts.

  2017cites this paper
• Human adipose tissue-derived stem cells inhibit the activity of keloid fibroblasts and fibrosis in a keloid model by paracrine signaling.

  2017cites this paper
• Non‐Coding RNAs: The New Insight on Hypertrophic Scar

  2017cites this paper
• The Long Non-Coding RNA LncRNA8975-1 is Upregulated in Hypertrophic Scar Fibroblasts and Controls Collagen Expression

  2016cites this paper
• Updates on Keloidal Wound Healing

  2016cites this paper